As of 2025-06-15, the Relative Valuation of Supernus Pharmaceuticals Inc (SUPN) is 26.65 USD. This relative valuation is based on P/E multiples. With the latest stock price at 32.03 USD, the upside of Supernus Pharmaceuticals Inc based on Relative Valuation is -16.8%.
The range of the Relative Valuation is 15.50 - 32.51 USD.
| Range | Selected | |
| Trailing P/E multiples | 14.0x - 29.4x | 22.0x |
| Forward P/E multiples | 18.0x - 21.5x | 20.4x |
| Fair Price | 15.50 - 32.51 | 26.65 |
| Upside | -51.6% - 1.5% | -16.8% |
| Date | P/E |
| 2025-06-13 | 28.97 |
| 2025-06-12 | 29.63 |
| 2025-06-11 | 29.98 |
| 2025-06-10 | 30.08 |
| 2025-06-09 | 30.09 |
| 2025-06-06 | 29.98 |
| 2025-06-05 | 29.25 |
| 2025-06-04 | 29.21 |
| 2025-06-03 | 29.15 |
| 2025-06-02 | 28.86 |
| 2025-05-30 | 28.67 |
| 2025-05-29 | 28.65 |
| 2025-05-28 | 29.07 |
| 2025-05-27 | 29.48 |
| 2025-05-23 | 29.03 |
| 2025-05-22 | 28.97 |
| 2025-05-21 | 29.51 |
| 2025-05-20 | 30.02 |
| 2025-05-19 | 29.89 |
| 2025-05-16 | 30.23 |
| 2025-05-15 | 29.37 |
| 2025-05-14 | 28.52 |
| 2025-05-13 | 29.19 |
| 2025-05-12 | 29.07 |
| 2025-05-09 | 28.67 |
| 2025-05-08 | 28.52 |
| 2025-05-07 | 27.98 |
| 2025-05-06 | 29.33 |
| 2025-05-05 | 29.29 |
| 2025-05-02 | 29.70 |
| 2025-05-01 | 29.35 |
| 2025-04-30 | 29.37 |
| 2025-04-29 | 29.38 |
| 2025-04-28 | 29.16 |
| 2025-04-25 | 29.14 |
| 2025-04-24 | 28.35 |
| 2025-04-23 | 27.89 |
| 2025-04-22 | 27.89 |
| 2025-04-21 | 27.39 |
| 2025-04-17 | 27.82 |
| 2025-04-16 | 27.77 |
| 2025-04-15 | 28.45 |
| 2025-04-14 | 28.58 |
| 2025-04-11 | 28.64 |
| 2025-04-10 | 28.10 |
| 2025-04-09 | 28.72 |
| 2025-04-08 | 27.71 |
| 2025-04-07 | 29.18 |
| 2025-04-04 | 29.61 |
| 2025-04-03 | 29.38 |